News

Stop TB Partnership Craig David Video Series #2

This is the second video in the series: “This is All Worthwhile”

Craig David with South African Schoolchildren

In this clip Craig talks to children about the effects of tuberculosis on young people, particularly the stigma they may face among their peers. He urges them to recognize the symptoms of tuberculosis and ask for help from a parent or teacher if they think they might be infected, reminding them that tuberculosis can be cured.

We see Craig interacting with kids outside the school, kicking around a football in the street, and sitting in the classroom, where he gives a poignant a cappella rendition of his hit “Walking Away”, accompanied by the delighted children beating out a rhythm on their desktops as he sings “I’m walking away… to find a better day”.

Visibly moved, Craig tells the group: “You guys, the fact that you understand it and you are aware makes me feel like this is all worthwhile.”

The video was produced by Fabrica – Benetton’s Research Centre on Communications. Four more videos will be released, one each week, between now and 7 July.

More News
17 Sep 2019
Earlier this month, the NIH announced two new Funding Opportunity Annoucnements (FOAs) on the topic of Myeloid-Derived Suppressor Cells (MDSC) as potential therapeutic targets in TB/HIV co-infected patients. The purpose of these FOAs is to invite applications for support of innovative clinical,...
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...